Ads
related to: cprx stock quotetradewins.com has been visited by 10K+ users in the past month
Search results
Catalyst (CPRX) Q4 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 2 months agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted diluted earnings of 53 cents per share for the...
Catalyst (CPRX) Q2 Earnings & Sales Top, 2023 Outlook Raised
Zacks via Yahoo Finance· 9 months agoShares of Catalyst Pharmaceuticals, Inc. CPRX climbed 6.4% on Thursday after the company reported...
Catalyst (CPRX) Settles Patent Dispute Over Sole Marketed Drug
Zacks via Yahoo Finance· 2 years agoCatalyst (CPRX) settles patent litigation disputes related to Firdapse, its LEMS drug. This...
Is Catalyst Pharmaceuticals (CPRX) Stock a Solid Choice Right Now?
Zacks via Yahoo Finance· 4 months agoOne stock that might be an intriguing choice for investors right now is Catalyst Pharmaceuticals,...
Catalyst Pharmaceuticals (NASDAQ:CPRX) pulls back 10% this week, but still delivers shareholders...
Simply Wall St. via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) shareholders might be concerned after seeing the share...
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past...
Simply Wall St. via Yahoo Finance· 2 months agoThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if...
Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 574%
Simply Wall St. via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) shareholders might be concerned after seeing the share...
Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y
Zacks via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals, Inc. CPRX reported earnings of 12 cents per share in the first quarter of...
Catalyst's (CPRX) Q3 Earnings & Revenues Surpass Estimates
Zacks via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals, Inc. CPRX reported earnings of 20 cents per share for the third quarter of...
Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera
Zacks via Yahoo Finance· 11 months agoCatalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North...
Ads
related to: cprx stock quotetradewins.com has been visited by 10K+ users in the past month
